Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Phase II clinical trial, open-labelled, prospective and single-center study directed to
obtain blood samples in experimental detailed conditions in order to compare and optimize the
dose of colistin in critically ill patients suffering from infections on which the indication
of colistin would be accepted according to normal local protocols for severe infections
treatment.
Phase:
Phase 1
Details
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla